• Home
• Guidelines
• Clinical Practice Guidelines
• EHA Guidelines by Topic

EHA Guidelines by Topic

AL Amyloidosis

• Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines (2021)
• Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group (2022)

Bleeding and thrombosis

• EHA Guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer (2022)

Bleeding disorders

• Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance (2023)
• Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report (2019)

Cardiovascular toxicity of anti-cancer treatments

• ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) (2022)

 CMML

• Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults (2018)

Anemia

• Recommendations regarding splenectomy in hereditary hemolytic anemias(2017)
• Management of Pregnancy in Rare Inherited Anemias (2020)
• The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper (2022)

Infections

• Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association (2022)

Multiple Myeloma

• Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up (2021)

Methemoglobinemia

• Recommendations for diagnosis and treatment of methemoglobinemia (2021)

Neutropenias

• The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action (2023)